Patient Trust In Pharma Is Low; Here’s How To Rebuild It

Published in Clinical Leader –
View Publication

Authors:
Shalome Sine and Annick de Bruin, CISCRP

This article is part of a quarterly series highlighting key insights from a global longitudinal survey study of over 12,800 patients and members of the public conducted in 2025. In this article, we will review what the survey results show about patient and public levels of trust in pharmaceutical companies, as well as specific strategies pharmaceutical companies can take to rebuild trust.